Your browser doesn't support javascript.
loading
Risk of malignant brain tumor as a second primary is significantly reduced after treatment of breast cancer.
Lehrer, Steven; Green, Sheryl; Rosenzweig, Kenneth E.
Affiliation
  • Lehrer S; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Green S; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Rosenzweig KE; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Breast J ; 24(2): 219-220, 2018 03.
Article in En | MEDLINE | ID: mdl-28727226
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms / Neoplasms, Second Primary / Glioblastoma / Aromatase Inhibitors Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms / Neoplasms, Second Primary / Glioblastoma / Aromatase Inhibitors Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast J Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States